Found 254 matching trials
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection PHASE2 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C PHASE3 This study is to evaluate the overall efficacy, and safety profile of the t...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection PHASE2 NAPs have been previously shown to clear serum hepatitis B virus surface an...
Show More Location
Infectious Clinical Hospital (n.a. Toma Ciorba) Department 5
Learn More & Join Trial
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment PHASE3 The purpose of this study is to determine the safety, efficacy and tolerabi...
Show More Location
Multiple Locations
Learn More & Join Trial
The Changes of Cytokines During Antiviral Therapy NA Pegylated interferon α-2a(Peg-IFN-α) not only inhibit viral replication, bu...
Show More Location
Beijing Ditan hospital,Capital Medical University
Learn More & Join Trial
REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection PHASE2 REP 2139-Ca is nucleic acid polymer. Nucleic acid polymers have been previo...
Show More Location
Infectious Clinical Hospital ( n.a. Toma Ciorba)
Learn More & Join Trial
Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) PHASE3 Acute hepatitis C is a liver disease related to a virus: hepatitis C virus ...
Show More Location
National Hepatology and Tropical Medicine Research Institute
Learn More & Join Trial